Biopharma firm Genelux gains on naming new CFO

Genelux

28/08/2023 16:11

** Biopharmaceutical company Genelux's  GNLX.O  shares up
6.8% at $23.97
    ** Company says Lourie Zak will join as CFO, effective Aug.
28
    ** Thomas Zindrick, company's president and CEO, will no
longer serve as Genelux's principal financial officer, company
says

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((rupali.chaudhary@thomsonreuters.com))